SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Platinum Partners Value Arbitrage Fund, LP

(Last)

(First)

(Middle)

C/O PLATINUM MANAGEMENT (NY) LLC

152 WEST 57TH STREET, 4TH FLOOR

(Street)

NEW YORK

10019

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
07/11/2013

3. Issuer Name and Ticker or Trading Symbol
Echo Therapeutics, Inc. [ ECTE ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	452,169	D⁽¹⁾⁽⁵⁾⁽⁶⁾
Common Stock	564,538	D⁽²⁾⁽⁵⁾⁽⁶⁾

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Series C Convertible Preferred Stock	⁽⁷⁾	⁽⁷⁾	Common Stock	311,308	$9.3	D⁽³⁾⁽⁵⁾⁽⁶⁾
Series C Convertible Preferred Stock	⁽⁷⁾	⁽⁷⁾	Common Stock	100,000	$9.3	D⁽²⁾⁽⁵⁾⁽⁶⁾
Series C Convertible Preferred Stock	⁽⁷⁾	⁽⁷⁾	Common Stock	586,110	$9.3	D⁽⁴⁾⁽⁵⁾⁽⁶⁾
Series D Convertible Preferred Stock	⁽⁷⁾	⁽⁷⁾	Common Stock	100,000	$10	D⁽²⁾⁽⁵⁾⁽⁶⁾
Series D Convertible Preferred Stock	⁽⁷⁾	⁽⁷⁾	Common Stock	200,600	$10	D⁽⁴⁾⁽⁵⁾⁽⁶⁾
Warrants	⁽⁸⁾	08/31/2017	Common Stock	400,000⁽⁸⁾	$20	D⁽⁴⁾⁽⁵⁾⁽⁶⁾
Warrants	⁽⁸⁾	09/20/2017	Common Stock	100,000⁽⁸⁾	$21.3	D⁽⁴⁾⁽⁵⁾⁽⁶⁾
Warrants	⁽⁸⁾	10/17/2017	Common Stock	50,000⁽⁸⁾	$22.7	D⁽⁴⁾⁽⁵⁾⁽⁶⁾
Warrants	⁽⁸⁾	11/06/2017	Common Stock	150,000⁽⁸⁾	$21.1	D⁽⁴⁾⁽⁵⁾⁽⁶⁾

1. Name and Address of Reporting Person^*

Platinum Partners Value Arbitrage Fund, LP

(Last)

(First)

(Middle)

C/O PLATINUM MANAGEMENT (NY) LLC

152 WEST 57TH STREET, 4TH FLOOR

(Street)

NEW YORK

10019

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Nordlicht Mark

(Last)

(First)

(Middle)

152 WEST 57TH STREET

4TH FLOOR

(Street)

NEW YORK

10019

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Platinum Management (NY) LLC

(Last)

(First)

(Middle)

152 WEST 57TH STREET

(Street)

NEW YORK

10019

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

LANDESMAN URI

(Last)

(First)

(Middle)

152 WEST 57TH STREET

4TH FLOOR

(Street)

NEW YORK

10019

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Platinum Long Term Growth VII, LLC

(Last)

(First)

(Middle)

152 WEST 57TH STREET

4TH FLOOR

(Street)

NEW YORK

10019

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Platinum Partners Liquid Opportunity Master Fund L.P.

(Last)

(First)

(Middle)

C/O PLATINUM MANAGEMENT (NY) LLC

152 WEST 57 STREET, 4TH FLOOR

(Street)

NEW YORK

10019

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Platinum-Montaur Life Sciences, LLC

(Last)

(First)

(Middle)

152 WEST 57TH STREET

4TH FLOOR

(Street)

NEW YORK

10019

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

Explanation of Responses:

1. Reflects the securities of the issuer owned directly by Platinum Partners Value Arbitrage Fund L.P. ("PPVA").

2. Reflects the securities of the issuer owned directly by Platinum Partners Liquid Opportunity Master Fund L.P., ("PPLO").

3. Reflects the securities of the issuer owned directly by Platinum Long Term Growth VII, LLC ("Platinum VII").

4. Reflects the securities of the issuer owned directly by Platinum-Montaur Life Sciences, LLC ("Platinum-Montaur").

5. The securities reported herein are held by Platinum VII, PPLO, Platinum-Montaur and PPVA. Platinum VII and Platinum-Montaur are subsidiaries of PPVA (collectively, the "Funds"). Platinum Management (NY) LLC ("Platinum Management") is the investment manager and general partner of PPVA and is the investment manager of Platinum VII and Platinum-Montaur. Platinum Liquid Opportunity Management (NY) LLC ("Platinum Liquid Management") is the investment manager of PPLO. Platinum Liquid Opportunity GP LLC is the general partner of PPLO. Mr. Nordlicht and Uri Landesman are the controlling persons of Platinum Management, Platinum Liquid Management and Platinum Liquid Opportunity GP LLC.

6. Platinum Management, Platinum Liquid Management, Platinum Liquid Opportunity GP LLC, Mark Nordlicht and Uri Landesman may each be deemed to indirectly beneficially own the securities held by the Funds. For purposes of this Form 3, Platinum Management, Platinum Liquid Management, Platinum Liquid Opportunity GP LLC and Messrs. Nordlicht and Landesman each disclaims beneficial ownership of the securities beneficially owned by the Funds, except to the extent of its or his pecuniary interest therein.

7. The Series C Convertible Preferred Stock and Series D Convertible Preferred Stock are immediately convertible into shares of common stock and do not have expiration dates.

8. The warrants are immediately exercisable. Pursuant to the terms of the warrants, the number of shares of common stock for which the warrants are exercisable is limited pursuant to the terms of the warrants to that number of shares of common stock which would result in the reporting persons having aggregate beneficial ownership of 4.99% of the total issued and outstanding shares of common stock (the "Ownership Limitation"). The warrants provide that Platinum-Montaur may waive such Ownership Limitation upon 61-days' prior written notice and increase such limitation up to 9.99%, which Platinum-Montaur has not done as of the date of this filing.

Remarks:

	Uri Landesman, President of Platinum Management (NY) LLC, as general partner of Platinum Partners Value Arbitrage Fund L.P.	07/22/2013
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.